93 related articles for article (PubMed ID: 2491440)
21. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
22. Anticancer antibodies.
Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
[TBL] [Abstract][Full Text] [Related]
23. Bi-specific antibody therapy for the treatment of cancer.
Withoff S; Helfrich W; de Leij LF; Molema G
Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
[TBL] [Abstract][Full Text] [Related]
24. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
[TBL] [Abstract][Full Text] [Related]
25. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
27. Novel radiolabeled antibody conjugates.
Goldenberg DM; Sharkey RM
Oncogene; 2007 May; 26(25):3734-44. PubMed ID: 17530026
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
[TBL] [Abstract][Full Text] [Related]
29. Engineering therapeutic monoclonal antibodies.
Liu XY; Pop LM; Vitetta ES
Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
[TBL] [Abstract][Full Text] [Related]
30. Basic immunology of antibody targeted radiotherapy.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S8-14. PubMed ID: 16979446
[TBL] [Abstract][Full Text] [Related]
31. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
32. Antibodies in the therapy of colon cancer.
Welt S; Ritter G
Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
[TBL] [Abstract][Full Text] [Related]
33. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
34. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of cell surface antigens for antibody targeting in oncology.
Carter P; Smith L; Ryan M
Endocr Relat Cancer; 2004 Dec; 11(4):659-87. PubMed ID: 15613445
[TBL] [Abstract][Full Text] [Related]
36. Technology evaluation: edrecolomab, Centocor Inc.
Abicht A; Lochmüller H
Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
[TBL] [Abstract][Full Text] [Related]
37. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
38. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].
Tokunaga T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954
[TBL] [Abstract][Full Text] [Related]
39. Technological advances in radioimmunotherapy.
Dearling JL; Pedley RB
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
Mulligan T; Carrasquillo JA; Chung Y; Milenic DE; Schlom J; Feuerstein I; Paik C; Perentesis P; Reynolds J; Curt G
Clin Cancer Res; 1995 Dec; 1(12):1447-54. PubMed ID: 9815943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
